Giving a Lecture

Our Team

 

An Extensive Network of Qualified Clinicians

Clinical Assessment Solutions has an extensive network of Physical Therapists with experience in rater training in clinical trials. This team of skilled clinicians are experts in protocol training and education to ensure that clinical evaluation testing is done confidently, consistently, and accurately, every time.


 

Leadership Team

 
Screen Shot 2020-05-28 at 7.29.19 PM.png

Mike Calcagni PT, DPT

Co-Founder Clinical Assessment Solutions

Michael Calcagni PT, DPT is co-founder of Clinical Assessment Solutions and a Doctor of Physical Therapy Practicing in the state of Rhode Island. Michael’s main clinical focus is on orthopedics and neuromuscular diseases. A significant amount of his caseload is focused on increasing the function and quality of life of patients with early onset Parkinson’s Disease. Michael uses functional outcome measures as part of his daily practice to ensure his interventions create measurable change in patients’ lives. He has been involved with clinical research as a consultant and clinical evaluator trainer on phase II and phase III rare neuromuscular disease trials. Michael has coordinated and led national and international investigator meetings and has consulted on script development and production of clinical outcome assessment training videos for site resources. 

Screen Shot 2020-05-28 at 5.13.50 PM.png

Brandon Lum, PT, DPT, OCS

Co-Founder Clinical Assessment Solutions

Brandon Lum is co-founder of Clinical Assessment Solutions and a Doctor of Physical Therapy practicing in Virginia. Brandon has been a clinician since 2006, working around the United States, specializing in orthopedics and neuromuscular disease. Brandon is a published researcher and wrote his doctoral project on using objective functional outcome measure data to justify patient improvement for the Centers for Medicare & Medicaid Services reporting. Brandon has taught clinical continuing education courses to both professional and non-professional staff and has experience as a clinical evaluator trainer on Phase III rare neuromuscular disease research. Brandon has coordinated and led national and international investigator meetings as well as consulted on training manual protocols and process improvement to ensure clear and concise uniformity for clinicians. He is an avid proponent of objective, evidenced-based practices and the use of research to guide patient treatments and to measure patient’s functional improvement.